Table 1.
Laboratory parameters in studied groups.
| UC flare mean (±SD) |
UC remission mean (±SD) |
CD flare mean (±SD) |
CD remission mean (±SD) |
Control mean (±SD) |
|
|---|---|---|---|---|---|
| TLC (103/L−6) | 6.7 ± 1.4 | 6.5 ± 1.5 | 8.9 ± 1.8* | 8.2 ± 0.6 | 7.7 ± 2.3 |
| Lymphocytes% | 39.2 ± 11.5 | 35.9 ± 12.9 | 38.5 ± 19.1 | 39.5 ± 16 | 45.8 ± 15.3 |
| Hemoglobin (gm/dL) | 9.6 ± 2.2* | 11.2 ± 1.2* | 9.8 ± 1.5* | 10.5 ± 1.6* | 12.3 ± 0.7 |
| Platelets (103/L−6) | 249 ± 63 | 257.3 ± 107.6 | 352.6 ± 175.4* | 346.5 ± 61.1* | 280 ± 31 |
| ESR (mm/hr) | 33.4 ± 8.9* | 30.2 ± 11.2* | 41.1 ± 5.7* | 34.3 ± 12.3* | 7.6 ± 3.1 |
| ALT (u/L) | 26.8 ± 4.4* | 27.9 ± 4.0* | 22.5 ± 7.1* | 26.5 ± 2.2* | 17.9 ± 6.2 |
| AST (u/L) | 33.9 ± 3.8* | 33.0 ± 3.6* | 28.7 ± 8.0* | 30.1 ± 5.3* | 17.9 ± 6.9 |
| Creatinine (mg/dL) | 0.39 ± 0.1 | 0.3 ± 0.1 | 0.27 ± 0.04 | 0.23 ± 0.04 | 0. 32 ± 0.14 |
Test of significance used is t-test for independent samples. *P < 0.05: significant in the patients groups in relation to controls.
UC: ulcerative colitis; CD: Crohn's disease.